4//SEC Filing
ACELRX PHARMACEUTICALS INC 4
Accession 0001437749-17-006460
$TLPHCIK 0001427925operating
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 5:29 PM ET
Size
8.0 KB
Accession
0001437749-17-006460
Insider Transaction Report
Form 4
Hamel Lawrence G
Chief Development Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2017-04-10−9,122→ 0 totalExercise: $1.20Exp: 2017-12-05→ Common Stock (9,122 underlying) - Award
Common Stock
2017-04-10$1.20/sh+9,122$10,946→ 73,475 total - Award
Common Stock
2017-04-10+6,879→ 80,354 total
Footnotes (2)
- [F1]Non-reportable acquisition of 6,879 shares of Common Stock through the Company's Employee Stock Purchase Plan.
- [F2]Options vest as follows: 1/4 of the shares subject to the option vest on December 4, 2008 with the remaining shares subject to the option vesting on an equal monthly basis over 36 months.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001427925
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 5:29 PM ET
- Size
- 8.0 KB